Cargando…
Flavokawain B Weakens Gastric Cancer Progression via the TGF-β1/SMAD4 Pathway and Attenuates M2 Macrophage Polarization
This study was designed to observe the treatment effects of flavokawain B (FKB) on gastric cancer both in SGC-7901 cells and nude mice. When SGC-7901 cells were exposed to 10 μg/mL FKB, cellular proliferative and apoptotic capacities and cell cycle were detected utilizing CCK-8 and flow cytometry as...
Autores principales: | Zhu, Yongzhao, Fan, Weining, Wang, Yuanzhen, Ding, Huan, Yang, Shaoqi, He, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9308533/ https://www.ncbi.nlm.nih.gov/pubmed/35879950 http://dx.doi.org/10.1155/2022/4903333 |
Ejemplares similares
-
Depiction of Aging-Based Molecular Phenotypes With Diverse Clinical Prognosis and Immunological Features in Gastric Cancer
por: He, Fang, et al.
Publicado: (2022) -
Hypoxia induces calpain activity and degrades SMAD2 to attenuate TGFβ signaling in macrophages
por: Cui, Wei, et al.
Publicado: (2015) -
Chalcone flavokawain A attenuates TGF‐β1‐induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE‐mediated antioxidant genes in vascular smooth muscle cells
por: Hseu, You‐Cheng, et al.
Publicado: (2018) -
The flavokawains: uprising medicinal chalcones
por: Abu, Nadiah, et al.
Publicado: (2013) -
Flavokawain A alleviates the progression of mouse osteoarthritis: An in vitro and in vivo study
por: Jing, Shaoze, et al.
Publicado: (2022)